Medivation, Inc. (NASDAQ: MDVN) confirmed that it has received an unsolicited, non-binding proposal from Sanofi to acquire all outstanding ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE